Free Trial

Jushi (OTCMKTS:JUSHF) Releases Earnings Results

Jushi logo with Medical background

Jushi (OTCMKTS:JUSHF - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.03), Zacks reports. The business had revenue of $63.85 million for the quarter, compared to analysts' expectations of $66.23 million.

Jushi Stock Down 8.6 %

OTCMKTS:JUSHF traded down $0.03 during trading hours on Friday, reaching $0.37. The company had a trading volume of 103,226 shares, compared to its average volume of 228,830. The firm has a market capitalization of $72.75 million, a PE ratio of -1.37 and a beta of -0.86. The stock has a 50-day moving average of $0.31 and a two-hundred day moving average of $0.33. Jushi has a one year low of $0.22 and a one year high of $0.78.

Jushi Company Profile

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Further Reading

Earnings History for Jushi (OTCMKTS:JUSHF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines